. 2015 Sep 6;5(5):419–430. doi: 10.1016/j.apsb.2015.07.006
© 2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 4.
Sialic acid and neuraminidase (NA) inhibitors.